BioRestorative Therapies Inc (BRTX) — Strategic Asset Allocation Index
BioRestorative Therapies Inc (BRTX) has a Strategic Asset Allocation Index of 4.0% as of June 2023. Strategic assets (PP&E of $497.81K plus long-term investments of $-) total $497.81K, measured against net assets of $12.40 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is BioRestorative Therapies Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
BioRestorative Therapies Inc Strategic Asset Allocation Index (2009–2022)
This chart shows how BioRestorative Therapies Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2009 to 2022. As of June 2023, the index stands at 4.0%, representing strategic assets of $497.81K against net assets of $12.40 Million USD. For live market cap and overall valuation, see market cap of BioRestorative Therapies Inc.
Annual Strategic Asset Allocation Index for BioRestorative Therapies Inc (2009–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for BioRestorative Therapies Inc from 2009 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See BRTX book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.9% | $502.76K | $502.76K | $- | $10.29 Million | ▲ +3.1 pp |
| 2021 | 1.8% | $395.80K | $395.80K | $- | $21.60 Million | ▲ +0.3 pp |
| 2009 | 1.5% | $112.00K | $112.00K | $- | $7.48 Million | — |